Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis.

Nardone R, Zuccoli G, Brigo F, Trinka E, Golaszewski S.

Rheumatology (Oxford). 2014 Feb;53(2):284. doi: 10.1093/rheumatology/ket364. Epub 2013 Nov 4. No abstract available.

PMID:
24191065
2.

Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis.

Nishimura K, Saegusa J, Kawano S, Morinobu A.

J Rheumatol. 2012 Sep;39(9):1904-5. doi: 10.3899/jrheum.120325. No abstract available.

PMID:
22942311
3.

Infliximab and reactivation of cerebral toxoplasmosis.

Young JD, McGwire BS.

N Engl J Med. 2005 Oct 6;353(14):1530-1; discussion 1530-1. No abstract available.

4.

Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.

Younis S, Rimar D, Slobodin G, Rosner I.

J Rheumatol. 2012 Oct;39(10):2055-6. doi: 10.3899/jrheum.120304. No abstract available.

PMID:
23028035
5.

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.

Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.

Int J Rheum Dis. 2012 Jun;15(3):330-5. doi: 10.1111/j.1756-185X.2012.01715.x. Epub 2012 Feb 13.

PMID:
22709496
6.

[Adalimumab induced-inflammatory myopathy in rheumatoid arthritis].

de Souza FH, Barros TB, Levy-Neto M, Shinjo SK.

Acta Reumatol Port. 2012 Apr-Jun;37(2):180-3. Portuguese.

PMID:
23149641
7.

Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.

Nagashima T, Minota S.

J Rheumatol. 2011 Mar;38(3):574; author reply 575. doi: 10.3899/jrheum.100947. No abstract available.

PMID:
21362792
8.

Sarcoid-related uveitis occurring during adalimumab therapy.

Seve P, Varron L, Broussolle C, Denis P, Kodjikian L.

Ocul Immunol Inflamm. 2012 Feb;20(1):59-60. doi: 10.3109/09273948.2011.623213. Epub 2011 Oct 21.

PMID:
22017197
9.

Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.

Grasland A, Sterpu R, Boussoukaya S, Mahe I.

Eur J Clin Pharmacol. 2012 May;68(5):895-8. doi: 10.1007/s00228-011-1191-4. Epub 2011 Dec 29. Review. No abstract available.

PMID:
22205272
10.

Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis.

Berry CE, Tsai J, Tierney A, Pickles R.

Med J Aust. 2013 Apr 1;198(6):331-3. No abstract available.

PMID:
23545033
11.

Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis.

Sauder MB, Glassman SJ.

Int J Dermatol. 2013 May;52(5):624-8. doi: 10.1111/j.1365-4632.2012.05707.x. Epub 2013 Mar 14.

PMID:
23489057
12.

A case of leukoencephalopathy associated with adalimumab-treated rheumatoid arthritis and a review of literature.

Ryu YS, Park SH, Kim JM, Kim EJ, Lee J, Kwok SK, Ju JH, Kim HY.

Rheumatol Int. 2012 Nov;32(11):3481-5. doi: 10.1007/s00296-011-2216-0. Epub 2011 Nov 8. Review.

PMID:
22065075
13.

Systemic listeriosis with adalimumab therapy.

Murphy G, Schmidt-Martin D, Hynes BG, Harney S.

J Clin Rheumatol. 2009 Oct;15(7):369-70. doi: 10.1097/RHU.0b013e3181bf93cd. No abstract available.

PMID:
20009978
14.

Adalimumab-induced neutropenia in a patient with rheumatoid arthritis.

Ottaviani S, Cerf-Payrastre I, Kemiche F, Pertuiset E.

Joint Bone Spine. 2009 May;76(3):312-3. doi: 10.1016/j.jbspin.2008.09.017. Epub 2009 Mar 16. No abstract available.

PMID:
19289296
15.

Endometrium cancer in a female with psoriatic arthritis treated with TNF alpha antagonist adalimumab.

Erten S.

Rheumatol Int. 2011 Nov;31(11):1537-8. doi: 10.1007/s00296-010-1661-5. Epub 2010 Dec 1. No abstract available.

PMID:
21120492
16.

Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.

van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA.

Rheumatology (Oxford). 2006 Oct;45(10):1317-9. Epub 2006 Jul 13. No abstract available.

PMID:
16844698
17.

Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.

Baltà-Cruz S, Alsina-Glbert M, Mozos-Rocafort A, Cervera C, Colomo-Saperas L, Del Río A, Estrach-Panella T.

Acta Derm Venereol. 2009;89(4):432-3. doi: 10.2340/00015555-0633. No abstract available.

18.

Alopecia universalis during treatment with leflunomide and adalimumab - case report.

Lazzarini R, Capareli GC, Buense R, Lellis RF.

An Bras Dermatol. 2014 Mar-Apr;89(2):320-2.

19.

Adalimumab for rheumatoid arthritis?

Ebell M, Kripke C.

Am Fam Physician. 2006 Feb 1;73(3):435-6. Review. No abstract available.

20.

Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?

Gabriel SE.

Arthritis Rheum. 2008 Mar;58(3):637-40. doi: 10.1002/art.23280. No abstract available.

Supplemental Content

Support Center